Investing Profile

Robert Tansley

InvestorVC
Partner at Cambridge Innovation Capital
cic.vc/team/Cambridge, United Kingdom
Photo of Robert Tansley, Partner at Cambridge Innovation Capital
Your Intro Paths to Robert Tansley

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Robert is a member of
University of Cambridge Network
348 CONNECTIONS
London Business School Network
182 CONNECTIONS
UCL Network
150 CONNECTIONS
Zinook Ltd. (Nasdaq: THCG Subsidiary) Network
45 CONNECTIONS
Zinook Ltd. (Nasdaq: THCG Subsidiary) Network
45 CONNECTIONS

Find Robert Tansley on

cb
Current Investing Position
Cambridge Innovation Capital Partner
Investment Range
$600K - $6.0M
Sweet Spot
$3.3M
Investments On Record
20
Current Fund Size
£225M

Robert Tansley is on these Sector & Stage Rankings

Robert Tansley's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
T-Therapeutics
Series ANov 2025$32M
Series ANov 2023$60M
$92M
Co-investors: Nihal Sinha (F-Prime Capital Partners), Graziano Seghezzi (Sofinnova Partners), Samuel Bjork (Digitalis Ventures)
Sortera Bio
Pre SeedJun 2025$10M
$10M
Microbiotica
Series UnknownAug 2024
Series BFeb 2022$68M
$73M
Co-investors: Isabelle de Cremoux (Seventure Partners)
CMR Surgical
Series DSep 2023$160M
Series DJun 2021$600M
Series CSep 2019$240M
Series BJun 2018$99M
Series ASep 2017$26M
Series AJul 2016$20M
$1.1B
Co-investors: Girish Nadkarni (TotalEnergies Ventures), Marta Pyrzyk (Lightrock)
Pretzel Therapeutics
Series ASep 2022$73M
$73M
Co-investors: David Schenkein (GV (Google Ventures)), Anika Gupta (GV (Google Ventures)), Per Samuelsson (HealthCap), Jay Parrish (ARCH Venture Partners), Reetika Bhardwaj (ARCH Venture Partners), Kristina Burow (ARCH Venture Partners), Alaa Halawa (Mubadala)
Gyroscope Therapeutics
Series CMar 2021$150M
Series BSep 2019$61M
$210M
Co-investors: Wouter Joustra (Forbion), Dmitrij Hristodorov (Forbion), Maha Katabi (Sofinnova Investments)
Inivata
Series BMar 2019$53M
Series AJan 2016$45M
Series UnknownSep 2014$7M
$110M
Congenica
Series BFeb 2017$10M
$130M
Co-investors: Hermann Hauser (Amadeus Capital Partners), Alastair Kilgour (Parkwalk Advisors), Ed Phillips (Future Planet Capital), Robert Walsh (QVentures)

Robert Tansley's Experience

Board Member InivataPresent
Board Member Zinook Ltd. (Nasdaq: THCG Subsidiary)Present
Board Member CongenicaPresent
Board Member ABCODIA LIMITEDPresent
Board Member STORM Therapeutics LimitedPresent
Board Member MORPHOGEN-IX LIMITED (acquired by Centessa Pharmaceuticals)Present
Board Member (2016-2019), Board Observer (2019-2021) CMR SurgicalPresent
Board Observer Carrick TherapeuticsPresent
Board Member MicrobioticaPresent
Board Member ashtabulacountymetroparksPresent
Board Member ExvastatPresent
Board Member PetMedixPresent
Board Member Pretzel TherapeuticsPresent
Board Member T-Therapeutics LtdPresent
Board Member BioIndustry Association (BIA)Present
Executive Chairperson Sortera BioPresent
Board Member Sortera BioPresent
Chief Medical Officer MicrobioticaPresent
Founder, CEO Zinook Ltd. (Nasdaq: THCG Subsidiary)Present
Founder, CEO Treague LtdPresent
Partner Cambridge Innovation CapitalPresent
Partner Cambridge Innovation Capital plcPresent
Venture Partner Cambridge Innovation CapitalPresent

Robert Tansley's Education

UCL MBBS Medicine
Faculty of Pharmaceutical Medicine Diploma of Pharmaceutical Medicine Distinction
London Business School MBA Distinction
University of Cambridge M.Phil Epidemiology & Biostatistics

Investors who invest with Robert Tansley

Sign in with Google →

Scouts & Angels Affiliated With Robert Tansley

Sign in with Google →